Recent pioneering research, which conducted positron emission tomography (PET) brain imaging on 130 patients across the aging/AD clinical spectrum, confirmed microglial activation as a critical determinant in the linkage of amyloid plague aggregation to tau spread and, subsequently, cognitive function impairment. This evidence concerns the gene MAPT and Alzheimer disease.